In 2018, the recommendations of the international evidence-based guidelines for the assessment and management of PCOS [1] indicated that, although its use is generally off label, metformin can be considered in addition to lifestyle in women with PCOS and Body Mass Index (BMI) 25 kg/m 2 to potentiate weight loss and to improve endocrine and metabolic outcomes
Start your consultation today.
It could also reduce markers of liver inflammatory activities and support reduction in body weight, fat mass, and hip circumference, all while being safe and well-tolerated
Our clinic uses FibroScan technology to monitor these improvements, allowing us to track liver health changes over time
Buse JB, Rosenstock J, Sesti G et al
Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrm PM